Publication | Closed Access

Inhibition of TGF-β induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase

Molecular PharmacologyAntifibrotic TherapyMolecular PhysiologyFibrosisLung InflammationMedicinePulmonary PharmacologyFibroblast Growth FactorPulmonary FibrosisSoluble Guanylyl CyclasePharmacologyCell BiologyDrug Discovery